Oncogenic transgelin-2 is differentially regulated in isocitrate dehydrogenase wild-type vs. mutant gliomas

The presence of an isocitrate dehydrogenase (IDH1/2) mutation in gliomas is associated with favorable outcomes compared to gliomas without the mutation (IDH1/2 wild-type, WT). The underlying biological mechanisms accounting for improved clinical outcomes in IDH1/2 mutant gliomas remain poorly unders...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyer, Sasha J., Bell, Erica H., McElroy, Joseph P., Fleming, Jessica L., Cui, Tiantian, Becker, Aline, Bassett, Emily, Johnson, Benjamin, Gulati, Pooja, Popp, Ilinca, Staszewski, Ori, Prinz, Marco, Grosu, Anca L., Haque, Saikh Jaharul, Chakravarti, Arnab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324682/
https://www.ncbi.nlm.nih.gov/pubmed/30647847
http://dx.doi.org/10.18632/oncotarget.26365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324682/
https://www.ncbi.nlm.nih.gov/pubmed/30647847
http://dx.doi.org/10.18632/oncotarget.26365

Ejemplares similares